These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 2086248)

  • 1. Regional differences in the prostanoid receptors mediating prostaglandin F2 alpha-induced contractions of cat isolated arteries.
    Nakajima M; Ueda M
    Eur J Pharmacol; 1990 Dec; 191(3):359-68. PubMed ID: 2086248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actions of a novel thromboxane A2-receptor antagonist, S-145, on isolated monkey and cat arteries.
    Nakajima M; Ueda M
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):502-9. PubMed ID: 2476633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle.
    Dorn GW; Becker MW; Davis MG
    J Biol Chem; 1992 Dec; 267(34):24897-905. PubMed ID: 1447225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a dilator function of 8-iso prostaglandin F2 alpha in rat pulmonary artery.
    Jourdan KB; Evans TW; Curzen NP; Mitchell JA
    Br J Pharmacol; 1997 Apr; 120(7):1280-5. PubMed ID: 9105703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the new thromboxane A2 antagonist vapiprost on isolated canine blood vessels.
    Matsuzaki T; Noguchi K; Nakasone J; Uezu K; Higuchi M; Sakanashi M
    Arzneimittelforschung; 1992 Nov; 42(11):1318-22. PubMed ID: 1492844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostanoid-induced contraction of human bronchial smooth muscle is mediated by TP-receptors.
    Coleman RA; Sheldrick RL
    Br J Pharmacol; 1989 Mar; 96(3):688-92. PubMed ID: 2720298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism underlying relaxations caused by prostaglandins and thromboxane A2 analog in isolated dog arteries.
    Toda N; Inoue S; Okamura T; Okunishi H
    J Cardiovasc Pharmacol; 1988 Mar; 11(3):354-62. PubMed ID: 2452930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of prostanoid-induced vascular contraction by 13-azaprostanoic acid (13-APA).
    Horn PT; Kohli JD; LeBreton GC; Venton DL
    J Cardiovasc Pharmacol; 1984; 6(4):609-13. PubMed ID: 6206314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 8-Epi-PGF2 alpha, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro.
    Kawikova I; Barnes PJ; Takahashi T; Tadjkarimi S; Yacoub MH; Belvisi MG
    Am J Respir Crit Care Med; 1996 Feb; 153(2):590-6. PubMed ID: 8564103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of thromboxane A2 antagonist GR32191B on prostanoid and nonprostanoid receptors in the human internal mammary artery.
    He GW; Yang CQ
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):13-9. PubMed ID: 7564353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
    Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the thromboxane-receptor antagonist L-636,499 on feline cerebral arteries.
    Uski TK; Andersson KE
    Acta Physiol Scand; 1986 Dec; 128(4):605-11. PubMed ID: 2949488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual variations of prostanoid agonist responses in rabbit aorta: evidence for the independent regulation of prostanoid receptor subtypes.
    Keith RA; Salama AI
    Br J Pharmacol; 1987 Sep; 92(1):133-48. PubMed ID: 3664085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of endothelium in the response to prostaglandin H2 in isolated dog arteries.
    Okamura T; Inoue S; Minami Y; Okunishi H; Toda N
    Jpn J Pharmacol; 1989 Apr; 49(4):511-21. PubMed ID: 2724690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of contraction-mediating prostanoid receptors in human hand veins: effects of the thromboxane receptor antagonists BM13,505 and AH23848.
    Arner M; Högestätt ED; Uski TK
    Acta Physiol Scand; 1991 Jan; 141(1):79-86. PubMed ID: 2053448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary artery constriction by the isoprostane 8-epi prostaglandin F2 alpha.
    Kromer BM; Tippins JR
    Br J Pharmacol; 1996 Nov; 119(6):1276-80. PubMed ID: 8937734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of contractile prostanoid receptors on human airway smooth muscle.
    Armour CL; Johnson PR; Alfredson ML; Black JL
    Eur J Pharmacol; 1989 Jun; 165(2-3):215-22. PubMed ID: 2776830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K; Halushka PV; Yan YT; Wong PY
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further characterization of the contraction-mediating prostanoid receptors in feline cerebral arteries. Effects of the thromboxane-receptor antagonist AH 23848.
    Uski TK
    Acta Physiol Scand; 1988 Aug; 133(4):519-24. PubMed ID: 2976236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BAY u3405, a potent and selective thromboxane A2 receptor antagonist on airway smooth muscle in vitro.
    McKenniff MG; Norman P; Cuthbert NJ; Gardiner PJ
    Br J Pharmacol; 1991 Nov; 104(3):585-90. PubMed ID: 1839139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.